Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

被引：0
|
作者：
R B Egerdie
F Saad
M R Smith
T L J Tammela
J Heracek
P Sieber
C Ke
B Leder
R Dansey
C Goessl
机构：
[1] Urology Associates Urologic Medical Research,Département de Chirurgie
[2] Centre Hospitalier de l’Université de Montréal,Departments of Hematology/Oncology and Medicine
[3] Massachusetts General Hospital Cancer Center,Department of Urology
[4] Tampere University Hospital,undefined
[5] Androgeos,undefined
[6] Urological Associates of Lancaster,undefined
[7] Amgen,undefined
[8] Massachusetts General Hospital Endocrine Unit,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2012年 / 15卷
关键词：
androgen deprivation; bone mineral density; bone loss; antiresorptive therapy; responder analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：308 / 312
页数：4
相关论文
共 50 条
  • [31] Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: Interim analysis of a multicenter phase 3 clinical study
    Smith, M. R.
    Malkowicz, S. B.
    Chu, F.
    Forrest, J.
    Price, D.
    Sieber, P.
    Barnette, K. G.
    Rodriguez, D.
    Steiner, M. S.
    JOURNAL OF UROLOGY, 2008, 179 (01): : 152 - 155
  • [32] Effect of androgen deprivation therapy on bone mineral density in patients with prostate cancer
    Ilyas, Kashaf
    Hafeez, Zainab
    Latif, Rukhsana
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (05) : 1175 - 1182
  • [33] Effect of androgen deprivation therapy on bone mineral density in prostate cancer patients
    Jun-Hong Deng
    Asian Journal of Andrology, 2004, (01) : 75 - 77
  • [34] Adverse bone effects in men with prostate cancer on androgen deprivation therapy
    Krupski, TL
    Smith, MR
    Lee, WC
    Pashos, CL
    Brandman, J
    Wang, Q
    Botteman, M
    Litwin, MS
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1581 - 1581
  • [35] Self-reported exercise and bone mineral density in prostate cancer patients receiving androgen deprivation therapy
    Mennen-Winchell, Lori J.
    Grigoriev, Victor
    Alpert, Patricia
    Dos Santos, Hildemar
    Tonstad, Serena
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2014, 26 (01) : 40 - 48
  • [36] Management of decreased bone mineral density (BMD) in men starting androgen deprivation therapy (ADT) for prostate cancer
    Panju, A. H.
    Breunis, H.
    Cheung, A. M.
    Duff-Canning, S.
    Fleshner, N. E.
    Krahn, M.
    Naglie, G.
    Tomlinson, G.
    Warde, P.
    Alibhai, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Contemporary Population-Based Analysis of Bone Mineral Density Testing in Men Initiating Androgen Deprivation Therapy for Prostate Cancer
    Hu, Jason
    Aprikian, Armen G.
    Vanhuyse, Marie
    Dragomir, Alice
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (10): : 1374 - +
  • [38] CONTEMPORARY POPULATION-BASED ANALYSIS OF BONE MINERAL DENSITY TESTING IN MEN INITIATING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
    Hu, Jason
    Aprikian, Armen
    Vanhuyse, Marie
    Dragomir, Alice
    JOURNAL OF UROLOGY, 2020, 203 : E963 - E964
  • [39] Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy
    S Yaturu
    S DjeDjos
    G Alferos
    C Deprisco
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 35 - 38
  • [40] Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy
    Yaturu, S
    DjeDjos, S
    Alferos, G
    Deprisco, C
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (01) : 35 - 38
12345